- Home
- NESR vs STOK Comparison
NESR vs STOK Comparison
Compare NESR & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NESR
- STOK
- Stock Information
- Founded
- NESR 2017
- STOK 2014
- Country
- NESR United States
- STOK United States
- Employees
- NESR N/A
- STOK N/A
- Industry
- NESR
- STOK Biotechnology: Pharmaceutical Preparations
- Sector
- NESR
- STOK Health Care
- Exchange
- NESR NYSE
- STOK Nasdaq
- Market Cap
- NESR 810.3M
- STOK 721.4M
- IPO Year
- NESR N/A
- STOK 2019
- Fundamental
- Price
- NESR $8.24
- STOK $11.68
- Analyst Decision
- NESR Strong Buy
- STOK Strong Buy
- Analyst Count
- NESR 2
- STOK 8
- Target Price
- NESR $14.00
- STOK $21.83
- AVG Volume (30 Days)
- NESR 149.4K
- STOK 667.4K
- Earning Date
- NESR 11-19-2024
- STOK 11-05-2024
- Dividend Yield
- NESR N/A
- STOK N/A
- EPS Growth
- NESR N/A
- STOK N/A
- EPS
- NESR 0.54
- STOK N/A
- Revenue
- NESR $1,265,542,000.00
- STOK $16,742,999.00
- Revenue This Year
- NESR $13.71
- STOK $103.66
- Revenue Next Year
- NESR $7.75
- STOK N/A
- P/E Ratio
- NESR $15.24
- STOK N/A
- Revenue Growth
- NESR 39.14
- STOK 81.08
- 52 Week Low
- NESR $7.68
- STOK $4.09
- 52 Week High
- NESR $9.89
- STOK $17.58
- Technical
- Relative Strength Index (RSI)
- NESR N/A
- STOK 44.25
- Support Level
- NESR N/A
- STOK $10.61
- Resistance Level
- NESR N/A
- STOK $12.58
- Average True Range (ATR)
- NESR 0.00
- STOK 0.95
- MACD
- NESR 0.00
- STOK -0.12
- Stochastic Oscillator
- NESR 0.00
- STOK 28.34
About NESR NATIONAL ENERGY SVCS REUNITED CORP
National Energy Services Reunited Corp is a British Virgin Islands-based company engaged in providing products and services to the oil and gas industry in the Middle East and North Africa and the Asia Pacific regions. The company has two reportable segments: Production Services including coil tubing, stimulation, and pumping, nitrogen services, completions, pipelines, cementing, laboratory services and filtration services; and Drilling and Evaluation Services including drilling and workover rigs, rig services, services, and well-testing services among others. Revenues are majorly derived from production services of an oil or natural gas well.
About STOK Stoke Therapeutics Inc.
Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.